ATTR amyloidosis was diagnosed based on the clinical findings, heterozygosity for the new TTR mutation, amyloid deposition in salivary glands and gastric tissue, and confirmation of the presence of the p.Gly87Arg variant within the deposits by tandem mass spectrometry-based proteomic analysis. Here, TTR is linked to amyloidosis.